199
Views
41
CrossRef citations to date
0
Altmetric
Original Article

Tumor Reoxygenation as a Mechanism of Taxol-Induced Enhancement of Tumor Radioresponse

, , , &
Pages 409-412 | Received 10 Oct 1994, Accepted 21 Dec 1994, Published online: 08 Jul 2009

References

  • Rowinsky E K, Onetto N, Canetta R M, Arbuck S G. Taxol: The first of the taxanes, an important new class of antitumor agents. Semin Oncol 1992; 19: 646–62
  • Schiff P B, Horwitz S B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980; 77: 1561–5
  • Tishler R B, Geard C R, Hall E J, Schiff P B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992; 52: 3495–7
  • Milas L, Hunter N R, Kurdoglu B, et al. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol 1995; 35: 297–303
  • Milas L, Hunter N R, Mason K A, Kurdoglu B, Peters L J. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 1994; 54: 3506–10
  • Long B H, Fairchild C R. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase. Cancer Res 1994; 54: 4355–61
  • Steren A, Sevin B U, Perras J, et al. Taxol sensitizes human ovarian cancer cells to radiation. Gynecol Oncol 1993; 48: 252–8
  • Liebmann J, Cook J A, Fisher J, Teague D, Mitchell J B. In vitro studies of taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 1994; 86: 441–6
  • Liebmann J, Cook J A, Fisher J, Teague D, Mitchell J B. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol). Int J Radiat Oncol Biol Phys 1994; 29: 559–64
  • Hall E J. Radiobiology for the radiologist. Ed 3. J. B. Lippincott, Philadelphia 1988
  • Milas L, Hunter N, Mason K, Withers H R. Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res 1974; 34: 61–71

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.